Recent research conducted by an international team of scientists has revealed that a protein, interleukin-11 (IL-11), plays a ...

The team demonstrated in preclinical models that the protein interleukin-11 (IL-11) actively promotes aging and that giving ...

A study in Nature demonstrates that blocking the signalling molecule interleukin-11 (IL-11) protects mice from age-associated pathologies and extends their lifespan. IL-11 is an understudied ...

Research from Imperial College London indicates that switching off a protein could lead to people living up to 25 per cent ...

The latest study centres around a drug involved in targeting interleukin-11, a protein involved in inflammation. Blocking this protein appeared to help mice stave off disease and extend their life ...

The team at the MRC Laboratory of Medical Science, Imperial College London and Duke-NUS Medical School in Singapore were investigating a protein called interleukin-11. Levels of it increase in the ...

IMNN-001 is the Company’s interleukin-12 (IL-12 ... plus standard-of-care in a first-line treatment setting include: An 11.1 month increase in median OS compared with standard-of-care alone ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Positive Results from OVATION 2 Trial Support Advancing IMNN-001 to ...

Interleukin (IL)-31 is a neuroimmune cytokine that is involved ... in itch intensity (as measured by the Peak-Pruritus Numerical Rating Scale [PP-NRS], an 11-point scale that assesses maximal ...

New research uncovers how COVID-19 may cause neuroinflammation, leading to persistent neurological symptoms even after recovery.

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for adult patients living with prurigo nodularis.

These data suggest an 11.1 month increase in median OS in the intent-to-treat ... to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, ...